FDA links Rheumatoid Arthritis Drug XELJANZ® to Serious Medical Conditions

FDA links RA Drug XELJANZ® to Serious Medical Conditions

If you or a loved one took the drug Xeljanz® amd Xeljanz® XR for rheumatoid arthritis, psoriatic arthritis or ulcerative colitis and suffered blood clots, cardiovascular problems or cancer you may have a claim for compensation. FDA safety alerts in 2019 and 2021 warned that Xeljanz® may increase the risk of blood clots, heart problems, death and cancer. [Read more here] In response to these findings, the make of Xeljanz® has recently modified the warnings for users of this drug. If you believe you may have a claim because of blood clots, cardiovascular problems or cancer diagnosed after using the medication Xeljanz® or Xeljanz® XR, please give us a call as soon as possible so that we can review your claim! Call Mat Richardson, Esq. at 251 410-7762 or email, mat@brwlawyers.com or you can talk with any of the lawyers at our firm, Boteler Richardson Wolfe – Injury Lawyers 251 433-7766, to learn more about your potential claim. No charge for consultations and no legal fees unless money is recovered for the client. Lawyers licensed in Florida, Alabama, Georgia and Mississippi.

REQUIRED DISCLAIMERS: Alabama Rule of Professional Conduct 7.2: No representation is made that the quality of legal service to be performed is greater than the services provided by other lawyers. The Mississippi Supreme Court advises that a decision on legal services is important and should not be based solely on advertisements. Free background information is available upon request to a Mississippi attorney. The listing of any area of practice by a Mississippi attorney does not indicate any certification of expertise therein. See Mississippi Rules of Professional Conduct Rule 7.2(d), Rule 7.4(a), Rule 7.6(a) (1997). Statement in compliance with Florida Bar Advertising Rules: “The hiring of a lawyer is an important decision that should not be based solely upon advertisements. Before you decide, ask us to send you free written information about our qualifications and experience. [Florida Rule 4-7.2(d)]. Georgia Rule of Professional Conduct 7.2 requires the physical location of the firm be disclosed: 3290 Dauphin Street, Suite 505, Mobile, AL 36606. General Disclaimer: This information is posted for general information purposes to help those interested parties or persons with potential civil claims better understand their rights and potential causes of action. If readers are currently represented by an attorney on the subject matter of this post then they are encouraged to continue with said representation. No attorney-client relationship is established by this post.

Hyper link for [Read more here] https://www.fda.gov/drugs/drug-safety-and-availability/fda-requires-warnings-about-increased-risk-serious-heart-related-events-cancer-blood-clots-and-death

What’s Up with the Zantac Recall Ads?

What’s Up with the Zantac Recall Ads?

On April 1, 2020, the FDA announced the immediate withdrawal of all prescription and over the counter Ranitidine and Zantac ® from the market. In its announcement, the agency stated that it “determined that the impurity in some ranitidine products increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels of this impurity.” The impurity, NDMA, is a known cancer causing chemical. Before April’s announcement, it was thought the impurity formed in the body. While this continues to be a common thought in the scientific community, thzantace FDA cautioned in its announcement that the impurity may result from when the drug is stored for longer periods of time at temperatures above 72 degrees. There are additional studies that will, hopefully, shed light on the reason for the impurity, but, for now, those studies have been delayed due to Covid-19.

According to studies of the contaminant NDMA (N-nitrosodimethylamine), possible side effects of ingestion are:

Bladder Cancer
Colorectal Cancer
Esophageal Cancer
Intestinal Cancer
Kidney Cancer
Liver Cancer
Ovarian Cancer
Pancreatic Cancer
Stomach Cancer
Testicular Cancer
Uterine Cancer

Currently, lawsuits and claims filed throughout the country have been consolidated in the U.S. Federal District Court for the Southern District of Florida through a multi-district litigation (MDL) process. While this litigation is in its infancy, there have been several thousand claims filed with the court through a census program. The utilization of this program is incredibly important as it will assist with determining the cause of the impurity found in ranitidine and Zantac ® and the effect NDMA has on the drug’s users.

Proof of cause and effect will be incredibly important and complex in this litigation as there are several hurdles consumers face in this litigation. For instance, those who were prescribed, generic Ranitidine was prescribed much more often than Zantac. This poses a significant problem as the U.S. Supreme Court has held that state law failure to warn claims against manufacturers of generic drugs are preempted be federal drug regulations. In other words, those consumers taking Ranitidine by prescription, only, are prohibited by law from making a claim against a generic manufacturer under a theory the company failed to warn the drug’s usage may cause cancer. Thus, in those cases, consumers will be forced to show evidence there is a defect in the manufacturing process of the generic manufacturer. Another concern, is proof of usage for those who purchased Ranitidine and Zantac ® over-the-counter. Requesting documents from pharmacy reward programs and/or medical savings accounts (MSA) will be imperative. Last, determining the manufacturer responsible for the consumer’s injury will be tasking; there are over 15 manufacturers of Ranitidine and Zantac ®. In summation, given the widespread usage of Ranitidine and Zantac ® and the complex evidentiary and legal theories that must be overcome by the consumer, this litigation pending in Miami, FL may, very well, take several years to reach a conclusion.

For more information related to this article and Ranitidine and Zantac ® claims, call Knox Boteler at 251-433-7766 or email, Knox@BRWlawyers.com

REQUIRED DISCLAIMERS: Alabama Rule of Professional Conduct 7.2: No representation is made that the quality of legal service to be performed is greater than the services provided by other lawyers. The Mississippi Supreme Court advises that a decision on legal services is important and should not be based solely on advertisements. Free background information is available upon request to a Mississippi attorney. The listing of any area of practice by a Mississippi attorney does not indicate any certification of expertise therein. See Mississippi Rules of Professional Conduct Rule 7.2(d), Rule 7.4(a), Rule 7.6(a) (1997). Statement in compliance with Florida Bar Advertising Rules: “The hiring of a lawyer is an important decision that should not be based solely upon advertisements. Before you decide, ask us to send you free written information about our qualifications and experience. [Florida Rule 4-7.2(d)]. General Disclaimer: This information is posted for general information purposes to help those interested parties or persons with potential civil claims better understand their rights and potential causes of action. If readers are currently represented by an attorney on the subject matter of this post then they are encouraged to continue with said representation. No attorney-client relationship is established by this post.

 

Polygrip Denture Cream

Polygrip Denture Cream’s manufacturer, GlaxoSmithKline, is under investigation for failing to inform users of this product’s potential safety risks. Polygrip Denture Cream contains 38 milligrams of zinc per ounce. Health experts recommend 8 milligrams of zinc per day for women and 11 milligrams for men. Medical studies have found excessive zinc may purge the body of copper, a chemical needed for normal brain and nervous system function. GlaxoSmithKline has announced that it will stop making Polygrip formulas containing zinc. Common side effects related to this product’s health risk include: loss of balance, loss of sensation in hands and feet and anemia. If you have any questions regarding your or a family member’s health and the use of Polygrip, please contact Knox Boteler at 866-975-7766 or email him at knox@bfw-lawyers.com for additional information. To learn more about this situation, click here.